Arne Soicke

Title: Arne Soicke - Innovator in Tumor Metastasis Inhibition

Introduction

Arne Soicke is a notable inventor based in Overath, Germany. He has made significant contributions to the field of cancer research, particularly in the development of compounds that inhibit tumor metastasis. His innovative work has the potential to impact the treatment of various tumor diseases.

Latest Patents

Arne Soicke holds a patent for "Inhibitors for inhibiting tumor metastasis." This invention relates to chemical compounds that serve as structural mimetics of proline-rich peptides. The compounds are designed to selectively inhibit ena/VASP-EVH1-mediated protein-protein interactions. Furthermore, these compounds can significantly inhibit the chemotaxis and motility of invasive tumor cells, making them valuable in the treatment and prevention of tumor metastases. He has 1 patent in this area.

Career Highlights

Throughout his career, Arne Soicke has worked with prominent organizations such as Forschungsverbund Berlin E.V. and Universität zu Köln. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Some of his notable coworkers include Ronald Kühne and Hans-Günther Schmalz. Their collaborative efforts have contributed to advancing research in tumor metastasis and related areas.

Conclusion

Arne Soicke's innovative work in developing inhibitors for tumor metastasis showcases his dedication to improving cancer treatment. His contributions to the field are significant and hold promise for future advancements in medical science.